BE854925A - Acides 12-azaprostanoiques utiles comme medicament - Google Patents

Acides 12-azaprostanoiques utiles comme medicament

Info

Publication number
BE854925A
BE854925A BE177817A BE177817A BE854925A BE 854925 A BE854925 A BE 854925A BE 177817 A BE177817 A BE 177817A BE 177817 A BE177817 A BE 177817A BE 854925 A BE854925 A BE 854925A
Authority
BE
Belgium
Prior art keywords
medicinal product
acids useful
azaprostanoic
azaprostanoic acids
useful
Prior art date
Application number
BE177817A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of BE854925A publication Critical patent/BE854925A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1782—Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/515—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an acetalised, ketalised hemi-acetalised, or hemi-ketalised hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
BE177817A 1976-05-24 1977-05-23 Acides 12-azaprostanoiques utiles comme medicament BE854925A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/689,318 US4022794A (en) 1976-05-24 1976-05-24 Novel analogs of prostaglandins with 4-oxo-thiazolidinyl nucleus and method of preparation thereof

Publications (1)

Publication Number Publication Date
BE854925A true BE854925A (fr) 1977-11-23

Family

ID=24767935

Family Applications (1)

Application Number Title Priority Date Filing Date
BE177817A BE854925A (fr) 1976-05-24 1977-05-23 Acides 12-azaprostanoiques utiles comme medicament

Country Status (13)

Country Link
US (1) US4022794A (fr)
JP (1) JPS52144669A (fr)
AU (1) AU511569B2 (fr)
BE (1) BE854925A (fr)
DE (1) DE2723237A1 (fr)
DK (1) DK206677A (fr)
ES (1) ES459050A1 (fr)
FR (1) FR2352808A1 (fr)
GB (1) GB1548820A (fr)
HU (1) HU178639B (fr)
NL (1) NL7705224A (fr)
SE (1) SE7705370L (fr)
ZA (1) ZA773055B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087435A (en) * 1977-02-17 1978-05-02 Merck & Co., Inc. 8-Aza-9-dioxothiaprostanoic acids
US4130566A (en) * 1977-10-27 1978-12-19 Sumitomo Chemical Company, Limited Process for producing 5-carboxy-2-acetylthiophene
US4402969A (en) * 1981-03-23 1983-09-06 Merck & Co., Inc. Antihypertensive proline derivatives
US4532138A (en) * 1981-11-20 1985-07-30 Syntex (U.S.A.) Inc. Thiazolidin-2-one analogs
US4866087A (en) * 1982-01-21 1989-09-12 Merck & Co., Inc. Carboxyalkyl urea compounds and derivatives thereof useful as angiotensin converting enzyme inhibitors and as antihypertensives
US4639460A (en) * 1985-08-05 1987-01-27 Chevron Research Company Fungicidal substituted N-(1-iodopropargyl)thiazolidinones
GB0014356D0 (en) * 2000-06-12 2000-08-02 Colover Jack Treatment of multiple sclerosis
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US7745442B2 (en) * 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
CA2728229A1 (fr) * 2008-05-09 2009-11-12 Allergan, Inc. Thiazolidinones, oxazolidinones therapeutiques substitues, et composes associes
JP2012184201A (ja) * 2011-03-07 2012-09-27 Nippon Zeon Co Ltd 環状エーテル化合物、非水系電池電極用バインダー組成物、非水系電池電極用スラリー組成物、非水系電池用電極及び非水系電池
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
NZ709197A (en) 2012-12-17 2020-06-26 Parion Sciences Inc 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
MX2015007796A (es) 2012-12-17 2015-09-04 Parion Sciences Inc Derivados de cloro-pirazin carboxamida con actividad bloqueadora sobre los canales de sodio epiteliales.
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU169072B (fr) * 1974-05-14 1976-09-28

Also Published As

Publication number Publication date
GB1548820A (en) 1979-07-18
NL7705224A (nl) 1977-11-28
ES459050A1 (es) 1978-11-01
HU178639B (en) 1982-06-28
AU2524177A (en) 1978-11-23
ZA773055B (en) 1979-01-31
US4022794A (en) 1977-05-10
SE7705370L (sv) 1977-11-25
AU511569B2 (en) 1980-08-28
FR2352808A1 (fr) 1977-12-23
JPS52144669A (en) 1977-12-02
DK206677A (da) 1977-11-25
DE2723237A1 (de) 1977-12-15
FR2352808B1 (fr) 1981-04-30

Similar Documents

Publication Publication Date Title
BE860049A (fr) Nouveaux benzamides substitues utilisables comme medicaments
BE866845A (fr) Composes thia-aza a noyau beta-lactame utiles notamment comme medicaments
SE7709359L (sv) Farmaceutisk doseringsform
BE854925A (fr) Acides 12-azaprostanoiques utiles comme medicament
BE839632A (fr) Medicament a base de sulfadiazine zincique
FR2331336A1 (fr) Acides oxy-4,4' bis(phenoxy-2 alcanocarboxyliques), leurs derives et leur application comme medicament
FR2338940A1 (fr) Nouveaux n-aryl-diazacycles oxygenes utiles comme medicaments
BE865624A (fr) Interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments
BE866057A (fr) Derives de l'aniline utilisables comme medicament
BE883495A (fr) Medicament hypolipemiqude a base de carnitine
BE866276A (fr) Composes a cycle beta-lactame, utilisables comme medicament
FR2353540A1 (fr) Nouveaux benzamides applicables comme medicaments
AU513829B2 (en) Modified montmorillonite pharmaceutical
BE860307A (fr) Compositions biologiquement actives utilisables comme medicament
FR2325374A1 (fr) Nouveaux pyridinecarboxamides a substituant basique utiles comme medicaments
FR2321294A1 (fr) Derives d'acides 7b-amino-3-cephem-3-carbonylmethyl-4-carboxyliques utiles comme medicaments
BE854171A (fr) 2-imino-thiazolidines et thiazolines utiles comme medicaments
BE868991R (fr) Nouveaux phenylazacycloalcanes utiles comme medicaments
FR2351979A1 (fr) Nouvel antibiotique de type thienamycine utile comme medicament
BE863137A (fr) Compositions pharmaceutiques a base d'acides alpha-mercapto-beta-arylacryliques
BE843255A (fr) Nouvelles amidines terpenoaromatiques utilisables comme medicament
BE876100A (fr) Nouvelles desoxyanthracyclines a activite antitumorale utilisables comme medicament
FR2340944A1 (fr) Derives de 2-aminomethyl-5-phenyloxazole utilisables comme medicaments anti-inflammatoires et analgesiques
FR2331329A1 (fr) Nouveaux d-homosteroides utiles comme medicaments
FR2348214A1 (fr) Nouveaux diazatetracyclo-dodecanes utiles comme medicaments

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MERCK & CO. INC.

Effective date: 19840523